Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES BIOCON ALKEM LABORATORIES/
BIOCON
 
P/E (TTM) x 37.3 19.7 189.1% View Chart
P/BV x 6.5 1.8 359.5% View Chart
Dividend Yield % 1.0 0.6 179.6%  

Financials

 ALKEM LABORATORIES   BIOCON
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
BIOCON
Mar-23
ALKEM LABORATORIES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs3,625388 934.8%   
Low Rs2,835192 1,479.6%   
Sales per share (Unadj.) Rs970.193.1 1,042.3%  
Earnings per share (Unadj.) Rs84.25.4 1,572.2%  
Cash flow per share (Unadj.) Rs110.214.6 753.2%  
Dividends per share (Unadj.) Rs50.001.50 3,333.3%  
Avg Dividend yield %1.50.5 299.0%  
Book value per share (Unadj.) Rs756.4146.5 516.2%  
Shares outstanding (eoy) m119.571,200.60 10.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.33.1 107.0%   
Avg P/E ratio x38.454.1 70.9%  
P/CF ratio (eoy) x29.319.8 148.0%  
Price / Book Value ratio x4.32.0 216.0%  
Dividend payout %59.428.0 212.0%   
Avg Mkt Cap Rs m386,207347,814 111.0%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31421,810 97.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,993111,742 103.8%  
Other income Rs m2,1617,681 28.1%   
Total revenues Rs m118,153119,423 98.9%   
Gross profit Rs m15,06516,611 90.7%  
Depreciation Rs m3,10411,131 27.9%   
Interest Rs m1,0744,190 25.6%   
Profit before tax Rs m13,0488,971 145.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9802,541 117.3%   
Profit after tax Rs m10,0686,430 156.6%  
Gross profit margin %13.014.9 87.4%  
Effective tax rate %22.828.3 80.6%   
Net profit margin %8.75.8 150.8%  
BALANCE SHEET DATA
Current assets Rs m86,064123,340 69.8%   
Current liabilities Rs m37,07185,107 43.6%   
Net working cap to sales %42.234.2 123.4%  
Current ratio x2.31.4 160.2%  
Inventory Days Days33129 25.3%  
Debtors Days Days67117 57.5%  
Net fixed assets Rs m37,245394,078 9.5%   
Share capital Rs m2396,003 4.0%   
"Free" reserves Rs m90,208169,926 53.1%   
Net worth Rs m90,447175,929 51.4%   
Long term debt Rs m0152,905 0.0%   
Total assets Rs m124,541517,418 24.1%  
Interest coverage x13.23.1 418.8%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.90.2 431.3%   
Return on assets %8.92.1 435.9%  
Return on equity %11.13.7 304.6%  
Return on capital %15.64.0 390.1%  
Exports to sales %14.63.1 470.0%   
Imports to sales %06.0 0.0%   
Exports (fob) Rs m16,9163,467 487.9%   
Imports (cif) Rs mNA6,654 0.0%   
Fx inflow Rs m16,9163,467 487.9%   
Fx outflow Rs m4,1906,654 63.0%   
Net fx Rs m12,727-3,187 -399.3%   
CASH FLOW
From Operations Rs m16,82518,525 90.8%  
From Investments Rs m1,128-142,818 -0.8%  
From Financial Activity Rs m-17,608130,487 -13.5%  
Net Cashflow Rs m4166,411 6.5%  

Share Holding

Indian Promoters % 56.7 40.4 140.6%  
Foreign collaborators % 0.0 20.3 -  
Indian inst/Mut Fund % 24.4 21.1 115.9%  
FIIs % 8.5 6.6 129.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 39.4 109.9%  
Shareholders   65,184 434,339 15.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Biocon Share Price Performance

Period ALKEM LABORATORIES Biocon S&P BSE HEALTHCARE
1-Day -1.85% 3.04% 1.18%
1-Month -1.67% -2.42% -0.75%
1-Year 51.22% 30.66% 61.82%
3-Year CAGR 21.42% -13.51% 18.16%
5-Year CAGR 22.82% -2.70% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.